The team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person.

Scientists zoom in on microbial messages at the molecular level to understand how the microbiome shapes health.

Novo Nordisk and Evotec selected three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases.

Harvard University joins Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center as the initial four academic institutions to participate in LAB eN².